what bpc 157 does BPC-157 - Peptide for Gut Health & Tissue Repair Should You Take BPC-157 Peptides?

In the short-term, placebo-controlled trial in adults with schizophrenia, the adverse event of presyncope was reported in 1/167 (0.6%) of patients treated with ABILIFY MAINTENA, while syncope and orthostatic hypotension were each reported in 1/172 (0.6%) of patients treated with placebo

The result was also reported the same day by ABC News, The Associated Press, and Reuters

Its applications include injury, pain, and digestive disorders

In addition, pairing with sterile empty vials or laboratory vials enhances safety and organization

For chronic gut conditions (ulcerative colitis, Crohn's), some protocols extend to 12 weeks before cycling off for 4 weeks

These peptides are usually administered through subcutaneous injection